David J. McConkey, PhD of Johns Hopkins Greenberg Bladder Cancer Institute gives his take on what specific drugs have potential…
Browsing: Acute Lymphoblastic Leukemia
David J. McConkey, PhD of Johns Hopkins Greensberg Bladder Cancer Institute gives his opinion on what physicians need to know…
David J. McConkey, PhD of Johns Hopkins Greensberg Bladder Cancer Institute discusses whether or not non-invasive imaging will be ready…
David J. McConkey of Johns Hopkins Greensberg Bladder Cancer Institute explains why some bladder cancer subtypes respond to immunotherapy and…
David J. McConkey, PhD of Johns Hopkins Greensberg Bladder Cancer Institute discusses genomics and how they change treatment for bladder…
David J. McConkey, PhD of Johns Hopkins Greenberg Bladder Cancer Institute discusses how genomics help our understanding of heterogeneity in…
Ana Aparicio, MD of MD Anderson Cancer Center discusses her opinion on whether or not BRCA1 and BRCA2 genetic testing…
Ian Tannock, MD, PhD, DSc, from the University of Toronto, Toronto, Canada, discusses the problems limiting the use of personalized…
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, introduces the SECOMBIT Phase II trial (NCT02631447)…
Matti Aapro, MD, from the Clinique de Genolier, Genolier, Switzerland, discusses initiatives such as All.Can, which aim to improve the…
Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses reasons for divergent outcomes of health technology…
Laurence Albiges, MD, PhD, from the Gustave Roussy Institute, Villejuif, France discusses the safety of cabozantinib treatment in metastatic renal…
Ian Tannock, MD, PhD, DSc, from the University of Toronto, Toronto, Canada, gives advice on presenting research at the European…
Francesco Florindi from the European Cancer Patient Coalition introduces new recommendations on fostering collaboration between cancer patient organizations and hospitals,…
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, gives an overview of the use of…
Matti Aapro, MD, from the Clinique de Genolier, Genolier, Switzerland discusses research on the benefits of pegfilgrastim over filgrastim in…
Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses his talk on divergent outcomes of health…
Laurence Albiges, MD, PhD, from the Gustave Roussy Institute, Villejuif, France discusses data on the efficacy of targeted therapies after…
Minh-Ha Tran, DO, Associate Medical Director, Transfusion Medicine, Pathology School of Medicine discusses Daratumumab could result in false positive reactivity…
Deepa Jeyakumar, MD, Assistant Clinical Professor, Division of Hematology/Oncology, UC Irvine Health discusses New Clinical Impacts on AML for 2017…
Deepa Jeyakumar, MD, Assistant Clinical Professor, Division of Hematology/Oncology, UC Irvine Health discusses AML Highlights from ASH 2016 at MOASC…
Lauren C. Pinter-Brown MD, FACP, Health Sciences Professor of Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC-Irvine discusses the…
Lauren C. Pinter-Brown MD, FACP, Health Sciences Professor of Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC-Irvine discusses practice…
Lauren C. Pinter-Brown MD, FACP, Health Sciences Professor of Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC-Irvine compares Obinutuzumab…
Gordon D. McLaren, M.D., University of California, Irvine, Irvine, CA, VA Long Beach Healthcare System, Long Beach, CA discusses how…
Gordon D. McLaren, M.D., University of California, Irvine, Irvine, CA, VA Long Beach Healthcare System, Long Beach, CA discusses the…
Gordon D. McLaren, M.D., University of California, Irvine, Irvine, CA, VA Long Beach Healthcare System, Long Beach, CA discusses the…
Yasir Khan, MD, UC Irvine Health outlines how early studies show that DOACS may be promising in VTE at the…
Yasir Khan, MD, UC Irvine Health, compares Low Molecular Weight Heparin vs. DOACS in the management of DVT and VTE…
Yasir Khan, MD, UC Irvine Health, outlines how DOACS studies may be practice changing for VTE at the MOASC Spotlight…
Angela Fleischman MD PhD, UC Irvine Health discusses how a Trametinib Early Study Shows Impressive Results for MPN at MOASC…
Angela Fleischman MD PhD, UC Irvine Health outlines the real world changes in MPN for 2017 at the MOASC Spotlight…
Angela Fleischman MD PhD, UC Irvine Health discusses the new developments in MPN for 2017 at the MOASC Spotlight on…
Aditi Choudhry, MD, Hematology Oncology Fellow UC Irvine discusses how Ibrutinib May Replace Chemotherapy in CLL at MOASC Spotlight on…
Aditi Choudhry, MD, Hematology Oncology Fellow UC Irvine discusses the 5 Year Experience With Ibrutinib in CLL at the MOASC…
Elizabeth Brém, MD, HS Clinical Assistant, Professor Chao Comprehensive Cancer Center discusses the Future of Relapse Refractory Treatment in Hodgkins…
Elizabeth Brém, MD, HS Clinical Assistant Professor, Chao Comprehensive Cancer Center discussing Incorporating immunotherapy in Hodgkins Lymphoma at the MOASC…
Elizabeth Brém, MD, HS Clinical Assistant Professor Chao Comprehensive Cancer Center discusses Using PET Scan for Early Stage Hodgkin Lymphoma…
Ana Aparicio, MD of MD Anderson Cancer Center discusses her presentation “Advances in the Understanding and Treatment of AR-Indifferent Disease,”…
Ana Aparicio, MD of MD Anderson Cancer Center gives her perspective on how to sequence commonly used agents in prostate…
Ana Aparicio, MD of MD Anderson Cancer Center gives her take on whether immunotherapy will be added to treatment guidelines…
Ana Aparicio, MD of MD Anderson Cancer Center discusses how the CHARTED and STAMPEDE trials impacted her treatment for patients…
Ana Aparicio, MD of MD Anderson Cancer Center discusses how and where does chemotherapy fit for treating patients with prostate…
Ana Aparicio, MD of MD Anderson Cancer Center gives her take on which prostate cancer patients should be treated with…
Aly-Khan Lalani, MD of Dana Farber Cancer Institute gives an overview of his poster presentation about proton pump inhibitors in…
Aly-Khan Lalani, MD of Dana Farber Cancer Institute gives his thoughts on the use of immunotherapy to treat patients with…
Aly-Khan Lalani, MD of Dana Farber Cancer Institute discusses the integration of immunotherapies into renal cell carcinoma at the 2017…
Aly-Khan Lalani, MD of Dana Farber Cancer Institute gives an overview of the research he found most interesting, which were…
Alexandra Drakaki, MD, PhD of University of California, Los Angeles gives an overview of the highlights in Bladder Cancer research…
Alexandra Drakaki, MD, PhD of University of California, Los Angeles discusses what physicians need to know about the progress that’s…